Q5XIS9
Gene name |
Prkd2 |
Protein name |
Serine/threonine-protein kinase D2 |
Names |
EC 2.7.11.13 , nPKC-D2 |
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
rno:292658 |
EC number |
2.7.11.13: Protein-serine/threonine kinases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
552-808 (Protein kinase domain) |
Relief mechanism |
PTM |
Assay |
|
Accessory elements
695-717 (Activation loop from InterPro)
Target domain |
552-808 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
Autoinhibited structure

Activated structure

1 structures for Q5XIS9
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q5XIS9-F1 | Predicted | AlphaFoldDB |
No variants for Q5XIS9
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for Q5XIS9 |
No associated diseases with Q5XIS9
10 regional properties for Q5XIS9
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 552 - 808 | IPR000719 |
domain | Pleckstrin homology domain | 398 - 512 | IPR001849 |
domain | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain | 138 - 189 | IPR002219-1 |
domain | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain | 265 - 315 | IPR002219-2 |
active_site | Serine/threonine-protein kinase, active site | 671 - 683 | IPR008271 |
binding_site | Protein kinase, ATP binding site | 558 - 581 | IPR017441 |
domain | Diacylglycerol/phorbol-ester binding | 136 - 150 | IPR020454-1 |
domain | Diacylglycerol/phorbol-ester binding | 152 - 161 | IPR020454-2 |
domain | Diacylglycerol/phorbol-ester binding | 292 - 303 | IPR020454-3 |
domain | Diacylglycerol/phorbol-ester binding | 304 - 316 | IPR020454-4 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.11.13 | Protein-serine/threonine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
6 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
Golgi apparatus | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
7 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
diacylglycerol-dependent serine/threonine kinase activity | Catalysis of the reaction |
metal ion binding | Binding to a metal ion. |
protein kinase activity | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction |
protein kinase C binding | Binding to protein kinase C. |
protein serine kinase activity | Catalysis of the reactions |
protein serine/threonine kinase activity | Catalysis of the reactions |
28 GO annotations of biological process
Name | Definition |
---|---|
adaptive immune response | An immune response mediated by cells expressing specific receptors for antigens produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory). |
angiogenesis | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
cell adhesion | The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules. |
cellular response to vascular endothelial growth factor stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus. |
intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
phospholipase C-activating G protein-coupled receptor signaling pathway | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of phospholipase C (PLC) and a subsequent increase in the intracellular concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG). |
phosphorylation | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
positive regulation of angiogenesis | Any process that activates or increases angiogenesis. |
positive regulation of blood vessel endothelial cell migration | Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels. |
positive regulation of cell adhesion | Any process that activates or increases the frequency, rate or extent of cell adhesion. |
positive regulation of DNA biosynthetic process | Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process. |
positive regulation of DNA-binding transcription factor activity | Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
positive regulation of endothelial cell chemotaxis | Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis. |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway | The series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to its receptor on the surface of a cell, which activates or increases the frequency, rate or extent of endothelial cell chemotaxis. |
positive regulation of endothelial cell migration | Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
positive regulation of endothelial cell proliferation | Any process that activates or increases the rate or extent of endothelial cell proliferation. |
positive regulation of ERK1 and ERK2 cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
positive regulation of fibroblast growth factor receptor signaling pathway | Any process that activates or increases the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity. |
positive regulation of interleukin-2 production | Any process that activates or increases the frequency, rate, or extent of interleukin-2 production. |
positive regulation of interleukin-8 production | Any process that activates or increases the frequency, rate, or extent of interleukin-8 production. |
positive regulation of intracellular signal transduction | Any process that activates or increases the frequency, rate or extent of intracellular signal transduction. |
positive regulation of NF-kappaB transcription factor activity | Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
positive regulation of T cell receptor signaling pathway | Any process that activates or increases the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
positive regulation of vascular endothelial growth factor receptor signaling pathway | Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity. |
regulation of T cell apoptotic process | Any process that modulates the occurrence or rate of T cell death by apoptotic process. |
T cell receptor signaling pathway | The series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell. |
vascular endothelial growth factor receptor signaling pathway | The series of molecular signals initiated by a ligand binding to a vascular endothelial growth factor receptor (VEGFR) on the surface of the target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
8 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
O94806 | PRKD3 | Serine/threonine-protein kinase D3 | Homo sapiens (Human) | SS |
Q15139 | PRKD1 | Serine/threonine-protein kinase D1 | Homo sapiens (Human) | EV |
Q9BZL6 | PRKD2 | Serine/threonine-protein kinase D2 | Homo sapiens (Human) | SS |
Q8K1Y2 | Prkd3 | Serine/threonine-protein kinase D3 | Mus musculus (Mouse) | SS |
Q62101 | Prkd1 | Serine/threonine-protein kinase D1 | Mus musculus (Mouse) | SS |
Q8BZ03 | Prkd2 | Serine/threonine-protein kinase D2 | Mus musculus (Mouse) | SS |
Q9WTQ1 | Prkd1 | Serine/threonine-protein kinase D1 | Rattus norvegicus (Rat) | SS |
O45818 | dkf-2 | Serine/threonine-protein kinase dkf-2 | Caenorhabditis elegans | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MAAAPSHPAG | LPCSPGPGSP | PPPGGSDLQS | LPPLLPQIPA | PGSGVSFHIQ | IGLTREFVLL |
70 | 80 | 90 | 100 | 110 | 120 |
PAASELAHVK | QLACSIVDQK | FPECGFYGLY | DKILLFKHDP | TSANLLQLVR | SAADIQEGDL |
130 | 140 | 150 | 160 | 170 | 180 |
VEVVLSASAT | FEDFQIRPHA | LTVHSYRAPA | FCDHCGEMLF | GLVRQGLKCD | GCGLNYHKRC |
190 | 200 | 210 | 220 | 230 | 240 |
AFSIPNNCSG | ARKRRLSSTS | LASGHSVRLG | SSESLPCTAE | ELSRSTTDLL | PRRPPSSSSS |
250 | 260 | 270 | 280 | 290 | 300 |
SSSSSFYTGR | PIELDKMLMS | KVKVPHTFLI | HSYTRPTVCQ | ACKKLLKGLF | RQGLQCKDCK |
310 | 320 | 330 | 340 | 350 | 360 |
FNCHKRCATR | VPNDCLGEAL | INGDVPMEEA | ADYSEADKSS | LSDELEDSGV | IPGSHAENAL |
370 | 380 | 390 | 400 | 410 | 420 |
HASEEEEGEG | GKAQSSLGYI | PLMRVVQSVR | HTTRKSSTTL | REGWVVHYSN | KDTLRKRHYW |
430 | 440 | 450 | 460 | 470 | 480 |
RLDCKCITLF | QNNTTNRYYK | EIPLSEILAV | EPAQNFSLVP | PGTNPHCFEI | ITANVTYFVG |
490 | 500 | 510 | 520 | 530 | 540 |
ETPGGAPGGP | SGQGTEAARG | WETAIRQALM | PVILQDAPSA | PGHTPHRQAS | LSISVSNSQI |
550 | 560 | 570 | 580 | 590 | 600 |
QENVDIATVY | QIFPDEVLGS | GQFGVVYGGK | HRKTGRDVAV | KVIDKLRFPT | KQESQLRNEV |
610 | 620 | 630 | 640 | 650 | 660 |
AILQSLRHPG | IVNLECMFET | PEKVFVVMEK | LHGDMLEMIL | SSEKGRLPER | LTKFLITQIL |
670 | 680 | 690 | 700 | 710 | 720 |
VALRHLHFKN | IVHCDLKPEN | VLLASADPFP | QVKLCDFGFA | RIIGEKSFRR | SVVGTPAYLA |
730 | 740 | 750 | 760 | 770 | 780 |
PEVLLNQGYN | RSLDMWSVGV | IMYVSLSGTF | PFNEDEDIND | QIQNAAFMYP | ASPWSHISSG |
790 | 800 | 810 | 820 | 830 | 840 |
AIDLINNLLQ | VKMRKRYSVD | KSLSHPWLQE | YQTWLDLREL | EGKMGERYIT | HESDDARWDQ |
850 | 860 | 870 | |||
FVSERHGTPA | EGDLGGACLP | QDHEMQGLAE | RISIL |